Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
44 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Duodenal Diseases" (44 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Recruiting Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction
Condition: Duodenal Obstruction
Intervention: Device: Enteral stenting
3 Recruiting UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
Condition: Peptic Ulcer
Interventions: Procedure: endoscopic adhesive powder;   Drug: epinephrine;   Device: Endoscopic Wound Dressing (Next Biomedical)
4 Not yet recruiting Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft
Conditions: Gastric Ulcer Induced by Antiplatelet Agent;   Ulcer of the Gastrointestinal Tract;   Proton Pump Inhibitor
Intervention: Drug: Pantoprazole
5 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
6 Recruiting Domestic Surgical Robot Clinical Study
Condition: Gastric Ulcer With Perforation But Without Obstruction,
Intervention: Procedure: robotic surgery
7 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
8 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo
9 Recruiting Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Condition: Peptic Ulcer
Interventions: Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
10 Recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
11 Not yet recruiting Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
Conditions: Gastric Ulcer;   Peptic Ulcer;   Gastrointestinal Diseases;   Digestive System Diseases;   Lansoprazole;   Anti-Ulcer Agents;   Gastrointestinal Agents;   Proton Pump Inhibitors;   Enzyme Inhibitors;   Molecular Mechanisms of Pharmacological Action
Interventions: Drug: TAK-438;   Drug: Lansoprazole;   Drug: TAK-438 Placebo;   Drug: Lansoprazole Placebo;   Drug: Bismuth-Containing Quadruple Therapy
12 Recruiting Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)
Conditions: Bleeding Peptic Ulcer;   Active Bleeding;   Gastrointestinal Bleeding
Interventions: Other: Urgent endoscopy;   Other: Early endoscopy
13 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
14 Not yet recruiting Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
Conditions: Gastroduodenal Ulcer;   Marginal Ulcer;   Peptic Ulcer Hemorrhage
Interventions: Drug: Omeprazole High dose;   Drug: Omeprazole Low dose
15 Recruiting Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: oral esomeprazole 20 mg twice daily;   Drug: oral esomeprazole 20 mg once daily
16 Recruiting Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
Condition: Peptic Ulcer Bleeding
Interventions: Device: Supplementary endoscopy with doppler-guided therapy;   Drug: IV. PPI;   Other: Endoscopic treatment at primary endoscopy
17 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Interventions: Procedure: epinephrine injection or heater probe or hemoclips;   Other: Observation only
18 Recruiting Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Condition: Bleeding Peptic Ulcers
Intervention: Device: Hemospray Kit
19 Recruiting TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy
Conditions: Peptic Ulcer;   Bleeding
Interventions: Procedure: Trans-catheter arterial embolization;   Procedure: Surgery
20 Recruiting Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
Condition: Gastric Ulcer
Interventions: Drug: CJ-12420 50 mg QD;   Drug: CJ-12420 100 mg QD;   Drug: Lansoprazole 30 mg QD

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.